Literature DB >> 5796782

Urinary hydroxyproline excretion in patients with cancer.

C E Guzzo, W N Pachas, R S Pinals, M J Krant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5796782     DOI: 10.1002/1097-0142(196908)24:2<382::aid-cncr2820240221>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

1.  Urinary hydroxyproline in the management of breast cancer.

Authors:  A Cuschieri
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

2.  The role of skeletal scintigraphy in detection of metastatic breast cancer.

Authors:  C S Galasko
Journal:  World J Surg       Date:  1977-05       Impact factor: 3.352

3.  Skeletal metastases and mammary cancer.

Authors:  C S Galasko
Journal:  Ann R Coll Surg Engl       Date:  1972-01       Impact factor: 1.891

4.  Urinary hydroxyproline excretion in carcinoma of the breast.

Authors:  A Cuschieri; R A Felgate
Journal:  Br J Exp Pathol       Date:  1972-06

5.  Urinary hydroxyproline levels in patients with prostatic carcinoma.

Authors:  D Erol; N Adalar; S Güvençli; F Simşek
Journal:  Int Urol Nephrol       Date:  1983       Impact factor: 2.370

6.  Free serum hydroxyproline and total urinary hydroxyproline for the detection of skeletal metastasis.

Authors:  A B Gasser; D Depierre; B Mermillod; B Courvoisier
Journal:  Br J Cancer       Date:  1982-03       Impact factor: 7.640

7.  Problems associated with the detection of skeletal metastases.

Authors:  C S Galasko
Journal:  J R Soc Med       Date:  1978-01       Impact factor: 18.000

8.  The role of tumour markers in predicting skeletal metastases in breast cancer patients with equivocal bone scintigraphy.

Authors:  A Nicolini; P Ferrari; A Sagripanti; A Carpi
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

9.  Relevance of hydroxyproline excretion to bone metastasis in breast cancer.

Authors:  F Gielen; J Dequeker; A Drochmans; J Wildiers; M Merlevede
Journal:  Br J Cancer       Date:  1976-09       Impact factor: 7.640

10.  Three-centre study on urinary hydroxyproline excretion in cancer of the breast.

Authors:  A Cuschieri; R Jarvie; W H Taylor; E Cant; C M Furnival; L H Blumgart
Journal:  Br J Cancer       Date:  1978-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.